Switch View
© Globe Newswire
16.09.2025
ISIN: JP3431300007
Nxera Pharma Co Ltd
45650
LISTED
XJPX
Nxera Pharma and Cancer Research UK Announce First Patient Dosed in Phase 2a Trial of Investigational Cancer Immunotherapy HTL0039732
News Preview
Tokyo, Japan and Cambridge and London, UK, 17 September 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) and Cancer Research UK announce that the first patient has been dosed in a Phase 2a clinical trial (NCT05944237) evaluating Nxera’s investigational immunotherapy drug HTL0039732 (also known as NXE0039732) for advanced solid tum...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Rosen Law Firm Urges Savara Inc. (NASDAQ: SVRA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, announces that an investor filed a class action lawsuit on behalf of purchasers of securities of Savara Inc. (NASDAQ: SVRA), between March 7, 2024 and May 23, 2025, both dates inclusive (the “Class Period”). Savara is a clinical-stage biopharmaceutical company.
For more information, submit a for...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
NASDAQ: LFMD INVESTOR ALERT: Berger Montague Advises LifeMD, Inc. (NASDAQ: LFMD) Investors of an October 27, 2025 Deadline
News Preview
PHILADELPHIA, Sept. 16, 2025 /PRNewswire/ -- Berger Montague PC, national plaintiffs' law firm, announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on behalf of investors who purchased or acquired shares during the period from May 7, 2025 through August 5, 2025 (the "Class Period")....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
16.09.2025
ISIN: US86150R1077
Stoke Therapeutics Inc
STOK
LISTED
NASDAQ
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
News Preview
Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effe...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
16.09.2025
ISIN: US29332G1022
Enhabit Inc
EHAB
LISTED
NYSE
Enhabit Announces Participation in Jefferies 2025 Healthcare Services Conference
News Preview
Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced its participation in the Jefferies 2025 Healthcare Services Conference.
Enhabit’s President and CEO Barb Jacobsmeyer and Chief Financial Officer Ryan Solomon will participate in a fireside chat on Tuesday, Sept. 30 at 10:55 a.m. CT. The fireside chat...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US64125C1099
Neurocrine Biosciences Inc
NBIX
LISTED
NASDAQ
Neurocrine Biosciences to Present New Data from Phase 2 Study of Osavampator in Adults with Major Depressive Disorder at 38th Annual Psych Congress 2025
News Preview
Additional Data from SAVITRI™ Study Expand on Top-Line Results Announced in April 2024SAVITRI Poster Presentation Chosen as Finalist for Psych Congress Poster AwardsSAN DIEGO, Sept. 16, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will present new data from the Phase 2 SAVITRI study of osavampator in ad...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US00857U1079
agilon health inc
AGL
LISTED
NYSE
agilon health to Participate in the 2025 Jefferies Healthcare Services Conference
News Preview
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that its management team will participate in a fireside chat at the 2025 Jefferies Healthcare Services Conference on Tuesday, September 30 at 8:45am ET.
Interested investors and other parties may listen to a sim...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US74051N1028
Premier Inc
PINC
LISTED
NASDAQ
Premier Infusion and Healthcare Services, Inc. (Premier Infusion and HCS) Selects Premier, Inc. as Its GPO Partner to Power Ambulatory Infusion Growth
News Preview
Premier, Inc. (NASDAQ: PINC), a leading technology-enabled healthcare performance improvement company, today announced that it has entered a five-year group purchasing agreement with Premier Infusion and Healthcare Services, Inc. (Premier Infusion and HCS). Premier Infusion and HCS is a closed-door infusion pharmacy based in Torrance, California,...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: IL0006290147
Teva Pharmaceutical Industries Ltd
TEVA
LISTED
TLV
Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV-‘749) on September 22, 2025 After Presentations at the Psych Congress Annual meeting
News Preview
TEL AVIV, Israel, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced plans to present data from the completed phase 3 SOLARIS trial at the 2025 Psych Congress Annual Meeting, taking place from September 17 – 21, 2025, in San Diego, California....
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Deadline Approaching: Savara Inc. (SVRA) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming November 7, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Savara Inc. (“Savara” or the “Company”) (NASDAQ: SVRA) securities between March 7, 2024 and May 23, 2025, inclusive (the “Class Period”).
IF YOU ARE AN INVESTOR WHO SUFF...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US7611521078
Resmed Inc
RMD
LISTED
NYSE
Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025
News Preview
SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the Bank of America Global Healthcare Conference 2025 on Tuesday, September 23, 2025, beginning at approximately 1:20 p.m. (British Summer Time)...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Cytokinetics Announces Proposed Private Placement of $550.0 Million of Convertible Senior Notes
News Preview
SOUTH SAN FRANCISCO, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (“Cytokinetics”) (Nasdaq: CYTK) today announced its intention to offer, subject to market conditions and other factors, $550.0 million aggregate principal amount of convertible senior notes due 2031 (the “notes”) in a private placement (the “offering”) to p...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
16.09.2025
ISIN: US50127T1097
Kura Oncology Inc
KURA
LISTED
NASDAQ
Kura Oncology Highlights Preclinical Data Demonstrating Potential of Farnesyl Transferase Inhibitors to Overcome Drug Resistance in Combination with Key Targeted Therapies Across Multiple Tumor Types
News Preview
Analyst/Investor event showcases opportunities for KO-2806 (darlifarnib) in combination with PI3Kα inhibitors, KRAS inhibitors and antiangiogenic tyrosine kinase inhibitors (TKIs)...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Encourages Lantheus Holdings, Inc. (LNTH) Investors To Inquire About Securities Fraud Class Action
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, inclusive (th...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US59503A2042
Microbot Medical Inc.
MBOT
LISTED
NASDAQ
Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
News Preview
$25.2 million in first closing and $4 million in second closing, with up to an additional approximately $63 million of potential aggregate gross proceeds upon the exercise in full of short-term preferred investment options $25.2 million in first closing and $4 million in second closing, with up to an additional approximately $63 million of potentia...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Carolina Complete Health and the Centene Foundation Award $1.3 Million Grant for Innovative Health Care Workforce Mental Health Program
News Preview
Multi-year initiative aims to combat clinician burnout and improve mental health support across North Carolina's healthcare workforce
DURHAM, N.C., Sept. 16, 2025 /PRNewswire/ -- The North Carolina Clinician and Physician Retention and Well-being (NCCPRW) Consortium announced today a transformative $1.3 million grant from the Centene Foundation,...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: US10920G1004
Bright Green Corp
BGXX
LISTED
NASDAQ
PharmAGRI Capital Partners Targets $10 Billion Federal Procurement Opportunity for Onshored Plant-Based Prescription Drugs Bright Green Corporation “BGXXQ” Q and A
News Preview
Fort Lauderdale, FL, Sept. 16, 2025 (GLOBE NEWSWIRE) -- PharmAGRI Capital Partners today announced its strategic focus on capturing a $10 billion total addressable market (TAM) in federal procurement of plant-based prescription drugs currently sourced from foreign manufacturers. This segment, while modest in size compared to the broader pharmaceu...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US03528H1095
Anixa Biosciences, Inc.
ANIX
LISTED
NASDAQ
Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals
News Preview
Issued on behalf of Oncolytics Biotech Inc.
VANCOUVER, BC, Sept. 16, 2025 /PRNewswire/ -- USA News Group News Commentary – The FDA's accelerated approval of two oncology treatments in August 2025[1] signaled the recent wave of regulatory momentum behind next-generation therapies. Meanwhile, advanced treatment platforms are achieving complete tumo...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US03528H1095
Anixa Biosciences, Inc.
ANIX
LISTED
NASDAQ
Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals
News Preview
Issued on behalf of Oncolytics Biotech Inc.
VANCOUVER, BC, Sept. 16, 2025 /PRNewswire/ -- USA News Group News Commentary – The FDA's accelerated approval of two oncology treatments in August 2025[1] signaled the recent wave of regulatory momentum behind next-generation therapies. Meanwhile, advanced treatment platforms are achieving complete tumo...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US03528H1095
Anixa Biosciences, Inc.
ANIX
LISTED
NASDAQ
Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals
News Preview
Issued on behalf of Oncolytics Biotech Inc.
VANCOUVER, BC, Sept. 16, 2025 /CNW/ -- USA News Group News Commentary – The FDA's accelerated approval of two oncology treatments in August 2025[1] signaled the recent wave of regulatory momentum behind next-generation therapies. Meanwhile, advanced treatment platforms are achieving complete tumor elimi...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US8106481059
scPharmaceuticals, Inc.
SCPH
LISTED
NASDAQ
SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH
News Preview
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of scPharmaceuticals Inc. (NasdaqGS: SCPH) to MannKind Corporation (NasdaqGM: MNKD). Under the terms of the proposed transaction, shareholders of scPharmaceuticals would receive a cash payment o...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US98888T1079
ZimVie, Inc.
ZIMV
LISTED
NASDAQ
ZIMVIE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ZimVie Inc. - ZIMV
News Preview
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of ZimVie Inc. (NasdaqGS: ZIMV) to an affiliate of ARCHIMED. Under the terms of the proposed transaction, shareholders of ZimVie will receive $19.00 in cash for each share of ZimVie that they ow...
Themefolio
Profiler
Peergroup
© ActuNews
16.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
OXURION : Axiodis CRO, de Franse dochtervennootschap van de Oxurion-groep, kondigt een dubbele strategische AI-initiatieven aan om klinische proeven te transformeren
News Preview
• Lancering van digitale tweelingen en virtuele patiënten om klinische studies te versnellen en te beveiligen
• Integratie van AI-modules in Exagis, de eigen eCRF-oplossing van Axiodis
Leuven, BELGIË, 16 september 2025, 18u00 – Oxurion NV (Euronext Brussel: OXUR) kondigt aan dat zijn dochtervennootschap Axiodis CRO, gespec...
Themefolio
Profiler
Peergroup
© ActuNews
16.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
OXURION : Axiodis CRO, the French subsidiary of the Oxurion Group, announces a dual AI-driven strategic initiative to transform clinical trials
News Preview
• Launch of digital twins and virtual patients to accelerate and enhance clinical trials
• Integration of AI modules into Exagis, Axiodis' proprietary eCRF solution
Leuven, BELGIUM, September 16, 2025, 6:00 PM – Oxurion NV (Euronext Brussels: OXUR) announces that its subsidiary, Axiodis CRO, specialized in clinical data manageme...
Themefolio
Profiler
Peergroup
© ActuNews
16.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
OXURION : Axiodis CRO, la filiale française du Groupe Oxurion annonce une double initiative stratégique autour de l'IA pour transformer les essais cliniques
News Preview
Lancement de jumeaux numériques et de patients virtuels pour accélérer et fiabiliser les essais cliniques.
Intégration de briques d'IA dans Exagis, solution eCRF propriétaire d'Axiodis.
Leuven, BELGIQUE, 16 septembre 2025, 18h00 - Oxurion NV (Euronext Bruxelles : OXUR), annonce que sa filiale Axiodis CR...
Themefolio
Profiler
Peergroup
© EQS Newswire
16.09.2025
ISIN: CH0012627250
HBM Healthcare Investments AG
HBMN
LISTED
SIX
Key Figures
15.09.2025
News Preview
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
15.09.2025
16.09.2025 / 17:47 CET/CEST
in CHF
Performance in %
15.09.2025
MTD
FYTD
CYTD
NAV
245.43
2.0
3.5
......
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Lilly announces plans to build $5 billion manufacturing facility in Virginia
News Preview
New site in Virginia's Goochland County will develop active pharmaceutical ingredients (API) in the U.S. for cancer, autoimmune and other advanced therapies
Company will create 2,450 high-wage manufacturing and construction jobs
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
INDIANAPOLIS, Sept. 1...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: FR0010259150
Ipsen SA
IPN
LISTED
EURONEXT
IPSEN - Buy-back programme - Art 5 of MAR - Week 37 - 2025
News Preview
Attachment...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: CH0012032048
Roche Holding AG
ROG
LISTED
SIX
Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience
News Preview
The integration of Accu-Chek SmartGuide's AI-enabled predictive CGM with the popular mySugr app delivers a simple, intuitive solution for people to manage their diabetes with greater ease.Accu-Chek SmartGuide is now available in 13 countries, with plans to accelerate access to over 30 countries across Europe, Latin America and Asia-Pacific by yea...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: CH0012032048
Roche Holding AG
ROG
LISTED
SIX
Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience
News Preview
The integration of Accu-Chek SmartGuide's AI-enabled predictive CGM with the popular mySugr app delivers a simple, intuitive solution for people to manage their diabetes with greater ease.Accu-Chek SmartGuide is now available in 13 countries, with plans to accelerate access to over 30 countries across Europe, Latin America and Asia-Pacific by yea...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene’s Individualized Neoantigen Therapeutic Cancer Vaccine TG4050 Delivers Positive Randomized Phase I Data Randomization to be Completed in Phase II Part in Q4 2025
News Preview
2025 Half-Year Results and Business Update...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
2025 Half-year financial information
News Preview
2025 Half-year financial information...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Availability of Transgene’s Half-Year Financial Report as of June 30, 2025
News Preview
TRANSGENE (Paris: TNG) today announced that it has made available to the public and filed with the Autorité des marchés financiers its half-year financial report as of June 30, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US1897631057
Co-Diagnostics Inc
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. Signs Strategic MOU with Partner in Kingdom of Saudi Arabia to Introduce Co-Dx™ PCR Platform to Middle East
News Preview
The Memorandum of Understanding includes the formation of a Joint Venture in the Kingdom of Saudi Arabia for manufacturing and distribution of the Company's upcoming Co-Dx™ PCR platform and other Co-Dx IP
SALT LAKE CITY, Sept. 16, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
STAAR Surgical Board of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders
News Preview
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it has filed its definitive proxy statement with the U.S. Securities and Exchange Commission in connection with the Company’s pending merger with Alcon (SIX/NYSE: ALC). S...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: KR7328130000
Lunit Inc.
328130
LISTED
KOE
Lunit Showcases AI-Powered Cancer Ecosystem at APEC High-Level Meeting on Health and the Economy and World Bio Summit 2025
News Preview
Lunit highlights global leadership in cancer AI alongside world health experts with dedicated APEC HLMHE session and WBS 2025 Leaders' Dialogue
SEOUL, South Korea, Sept. 16, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced its participation in two major global health gat...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Baxter Launches Welch Allyn Connex 360 Vital Signs Monitor to Advance Connected Patient Monitoring
News Preview
Baxter International Inc. (NYSE:BAX), a leading global medtech company, today launched the Welch Allyn Connex 360 Vital Signs Monitor, its next generation patient monitoring device. As the latest innovation in Baxter’s connected monitoring portfolio, Connex 360 offers an advanced connectivity and security platform, customizable configurations base...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lost Money on Lantheus Holdings, Inc.(LNTH)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Lantheus Holdings, Inc. ("Lantheus Holdings, Inc." or the "Company") (NASDAQ: LNTH) of a class action securities lawsuit.
CLASS DEFINITION: Th...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
Investors in RxSight, Inc. Should Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - RXST
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in RxSight, Inc. ("RxSight, Inc." or the "Company") (NASDAQ: RXST) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to r...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Levi & Korsinsky Notifies Shareholders of Nutex Health Inc.(NUTX) of a Class Action Lawsuit and an Upcoming Deadline
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit se...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US02157Q1094
Alto Neuroscience, Inc.
ANRO
LISTED
NYSE
Alto Neuroscience, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ANRO
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Alto Neuroscience, Inc. ("Alto Neuroscience, Inc." or the "Company") (NYSE: ANRO) of a class action securities lawsuit.
CLASS DEFINITION: The...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Semler Scientific, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 28, 2025 to Discuss Your Rights - SMLR
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Semler Scientific, Inc. ("Semler Scientific, Inc." or the "Company") (NASDAQ: SMLR) of a class action securities lawsuit.
CLASS DEFINITION: Th...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 25, 2025 to Discuss Your Rights - LFMD
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in LifeMD, Inc. ("LifeMD, Inc." or the "Company") (NASDAQ: LFMD) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to rec...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
November 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against SVRA
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Savara Inc. ("Savara Inc." or the "Company") (NASDAQ: SVRA) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recov...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US90466Y1038
Unicycive Therapeutics, Inc.
UNCY
LISTED
NASDAQ
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) - October 14, 2025 Deadline to Join - Contact Levi & Korsinsky
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. ("Unicycive Therapeutics, Inc." or the "Company") (NASDAQ: UNCY) of a class action securities lawsuit.
CLASS DEFI...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
Replimune Group, Inc. Class Action: Levi & Korsinsky Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 - REPL
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. ("Replimune Group, Inc." or the "Company") (NASDAQ: REPL) of a class action securities lawsuit.
CLASS DEFINITION: The la...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US29405E2081
Enveric Biosciences, Inc.
ENVB
LISTED
NASDAQ
Enveric Biosciences Receives FDA Response and Streamlines Plans for EB-003 IND Submission
News Preview
Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced that it has received a written response from the U.S. Food and Drug Administration (FDA) to its request for a Pre-Investigational New...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US8753722037
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
Tandem Diabetes Care Announces Publication Showing Adults With Type 2 Diabetes Benefit from Automated Insulin Delivery Regardless of C-Peptide Levels
News Preview
Tandem Diabetes Care® (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today announced the publication of a study, "Adults with Type 2 Diabetes Benefit from Automated Insulin Delivery Irrespective of C-peptide Level," in the American Diabetes Association’s Diabetes Care. The study, a sub-analysis from the 2IQP randomized,...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC LEI: 5493003YBCY4W1IMJU04 NET ASSET VALUE The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 15 September 2025 was 349.21p (cum income). For and on behalf of the B...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US44148G2049
Hoth Therapeutics, Inc.
HOTH
LISTED
NASDAQ
Hoth Therapeutics Issues Shareholder Update: HT-001, HT-KIT, Expanded Treasury Reserve Strategy, and VA Obesity Program Drive Strongest Position in Company History
News Preview
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company, today announced a comprehensive shareholder update, underscoring momentum across its lead clinical programs and corporate strategy. With HT-001 advancing globally, HT-KIT achieving key validation milestones, the expansion o...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US54948X1090
Lucid Diagnostics Inc.
LUCD
LISTED
NASDAQ
Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs
News Preview
Scelfo to strengthen and scale Lucid's market access infrastructure ahead of key upcoming reimbursement milestones—including Medicare coverage for EsoGuard—and to accelerate commercial coverage expansion
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage cancer prevention...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US9467841055
Waystar Holding Corp.
WAY
LISTED
NASDAQ
Waystar Advances AI Leadership with Next-Generation Denial Prevention and Reimbursement Recovery Innovations
News Preview
Tackling $20 billion lost in denial recovery efforts and $17 billion in uncompensated care, helping providers unlock stronger financial performance and resilience
LEHI, Utah and LOUISVILLE, Ky., Sept. 16, 2025 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today will unveil breakthrough innovations at it...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: US22407B1089
Coya Therapeutics, Inc.
COYA
LISTED
NASDAQ
Coya Therapeutics' COYA 303 Shows Promising Central Nervous System (CNS) Anti-inflammatory Effects and Systemic Regulatory T Cell (Treg) Enhancing Effects in a Preclinical Animal Inflammation Model
News Preview
COYA 303 is an investigational proprietary combination of LD-IL-2 and GLP-1RA for subcutaneous administration, under development for the treatment of diseases, including Alzheimer's Disease, driven by chronic and sustained inflammation;
COYA 303 demonstrated significant attenuation of neuroinflammation in cortex and hippocampus brain regions and...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US46266C1053
IQVIA Holdings Inc
IQV
LISTED
NYSE
IQVIA Receives WCG Pinnacle Award for Excellence in Site Relationships
News Preview
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, has been honored with the WCG Pinnacle Award for Site Relationships in Professionalism and Communication. The award recognizes IQVIA’s commitment to building strong, collaborativ...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: US8740602052
Takeda Pharmaceutical Company
TAK
LISTED
NYSE
Takeda and VELA to Ship Medicines Across the Atlantic Using First-of-its-Kind Wind-Powered Trimaran
News Preview
Takeda (TSE:4502/NYSE:TAK) and VELA Transport today announced their business partnership, with Takeda set to become the first biopharmaceutical company to transport its products between Europe and the U.S. using VELA’s first-of-its-kind sailing cargo trimaran. VELA designed and will operate a fleet of new generation sailing cargo vessels, powered...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ISIN: CH0432492467
Alcon AG
ALC
LISTED
NYSE
Alcon Announces New Time and Motion Study Results Supporting Superior Efficiency* for Cataract and Vitreoretinal Surgery with UNITY VCS
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, announced results from time and motion studies demonstrating superior efficiency* with UNITY® Vitreoretinal Cataract System (VCS) for vitreoretinal and cataract surgery compared to CONSTELLATION® Vision System and CENTURION® Vision System with ACTIVE...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: INE0DK501011
Piramal Pharma Limited
PPLPHARMA
LISTED
BSE
Piramal Pharma Solutions Augments Formulation Capabilities with the Addition of New Korsch XM-12 Bilayer Tablet Press at its Morpeth, UK Facility
News Preview
This tablet press will provide the facility's Formulation Development Team with an important tool for developing fixed dose combinations and modified release drug delivery. Piramal Pharma Solutions has implemented robust training protocols to ensure safe operation and high-quality output from the XM-12. MUMBAI, India, Sept. 16, 2025 /PRNewswire/...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: INE0DK501011
Piramal Pharma Limited
PPLPHARMA
LISTED
BSE
Piramal Pharma Solutions Augments Formulation Capabilities with the Addition of New Korsch XM-12 Bilayer Tablet Press at its Morpeth, UK Facility
News Preview
This tablet press will provide the facility's Formulation Development Team with an important tool for developing fixed dose combinations and modified release drug delivery. Piramal Pharma Solutions has implemented robust training protocols to ensure safe operation and high-quality output from the XM-12. MUMBAI, India, Sept. 16, 2025 /PRNewswire/...
Themefolio
Profiler
Peergroup
© PR Newswire
16.09.2025
ISIN: INE0DK501011
Piramal Pharma Limited
PPLPHARMA
LISTED
BSE
Piramal Pharma Solutions Augments Formulation Capabilities with the Addition of New Korsch XM-12 Bilayer Tablet Press at its Morpeth, UK Facility
News Preview
This tablet press will provide the facility's Formulation Development Team with an important tool for developing fixed dose combinations and modified release drug delivery. Piramal Pharma Solutions has implemented robust training protocols to ensure safe operation and high-quality output from the XM-12. MUMBAI, India, Sept. 16, 2025 /CNW/ -- Pira...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: CA92767B1058
Vireo Growth Inc
VREO
LISTED
CSE
Vireo Growth Inc. Announces Launch of Adult-Use Cannabis Sales in Minnesota
News Preview
– Company now dispensing adult-use cannabis at all eight Green Goods® dispensaries in Minnesota –...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
